Abstract:The viral capsid performs critical functions during HIV-1 infection and is a validated target for antiviral therapy. Previous studies have established that the proper structure and stability of the capsid are required for efficient HIV-1 reverse transcription in target cells. Moreover, it has recently been demonstrated that permeabilized virions and purified HIV-1 cores undergo efficient reverse transcription in vitro when the capsid is stabilized by addition of the host cell metabolite inositol hexakisphosphate (IP6). However, the molecular mechanism by which the capsid promotes reverse transcription is undefined. Here we show that wild type HIV-1 virions can undergo efficient reverse transcription in vitro in the absence of a membrane-permeabilizing agent. This activity, originally termed "natural endogenous reverse transcription" (NERT), depends on expression of the viral envelope glycoprotein during virus assembly and its incorporation into virions. Truncation of the gp41 cytoplasmic tail markedly reduced NERT activity, suggesting that gp41 licenses the entry of nucleotides into virions. By contrast to reverse transcription in permeabilized virions, NERT required neither the addition of IP6 nor a mature capsid, indicating that an intact viral membrane can substitute for the function of the viral capsid during reverse transcription in vitro . Collectively, these results demonstrate that the viral capsid functions as a nanoscale container for reverse transcription during HIV-1 infection. HIV-1 infection is critically dependent on reverse transcription, or copying of the viral RNA into DNA, following entry of the viral core in target cells. Reverse transcription depends on the stability of the capsid, yet the precise function the capsid serves during the reaction has not been established. Here we show that the viral capsid functions as a container for the reaction. Addition of dNTPs to intact virions in the absence of a permeabilizing agent resulted in efficient reverse transcription (NERT). Analysis of HIV-1 mutants revealed that the reaction depends on the cytoplasmic domain of gp41, confirming an earlier report. By contrast to the reaction in permeabilized virions, NERT required neither a stable nor a mature capsid, nor was it affected by the capsid-destabilizing inhibitor PF74. NERT also occurred in HIV-1 particles produced in various T cell lines and in simian immunodeficiency particles. Our results demonstrate that the capsid serves a container role in HIV-1 reverse transcription and suggest that it remains fully intact during reverse transcription in target cells. They further suggest that the gp41 protein can permeabilize membranes to nucleotides, potentially contributing to viral dissemination and pathogenesis in the infected host.

HIV-1 infection reduces NAD capping of host cell snRNA and snoRNA

A New Mechanism of SAMHD1 Inhibition of HIV-1 Infection by Induction of Autophagy

Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice

Stochastic nature and physiological implications of 5′-NAD RNA cap in bacteria

The nuclear pore protein NUP98 impedes LTR-driven basal gene expression of HIV-1, viral propagation, and infectivity

NAD deficiency contributes to progressive kidney disease in HIV nephropathy mice

The HIV-1 capsid serves as a nanoscale reaction vessel for reverse transcription

Nucleolin/Nsr1p binds to the 3' noncoding region of the tombusvirus RNA and inhibits replication.

Acetylation of cytidine residues boosts HIV-1 gene expression by increasing viral RNA stability

The lncRNA NRON modulates HIV-1 replication in a NFAT-dependent manner and is differentially regulated by early and late viral proteins

Transportin-1 binds to the HIV-1 capsid via a nuclear localization signal and triggers uncoating

RNA Deep Sequencing Analysis Reveals That Nicotine Restores Impaired Gene Expression by Viral Proteins in the Brains of HIV-1 Transgenic Rats

Internal RNA 2'-O-methylation on the HIV-1 genome impairs reverse transcription

Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.

HIV-1 capsid stability and reverse transcription are finely balanced to minimize sensing of reverse transcription products via the cGAS-STING pathway

CRNKL1 Is a Highly Selective Regulator of Intron-Retaining HIV-1 and Cellular mRNAs

Effect of transcription inhibition and generation of suppressive viral non-coding RNAs

HIV-1-encoded antisense RNA suppresses viral replication for a prolonged period

Importin KPNA2 confers HIV-1 pre-integration complex nuclear import by interacting with the capsid protein

HIV-1 nucleocapsid traps reverse transcriptase on nucleic acid substrates

Cationic Residues of the HIV-1 Nucleocapsid Protein Enable DNA Condensation to Maintain Viral Core Particle Stability during Reverse Transcription